Table 2.
Survey completion over timepoints, in active participants* who initiated surveys on day 0 or day 1 for each dose.
| mRNA vaccines (Pfizer-BioNTech and Moderna) |
Janssen vaccine |
|||||
|---|---|---|---|---|---|---|
| Survey Timepoint |
Dose 1 N = 5902402 |
Dose 2 N = 4516506 |
Dose 3 N = 662316 |
Dose 1 N = 348783 |
Dose 2 N = 7062 |
Dose 3 N = 705 |
| % Completion | % Completion | % Completion | % Completion | % Completion | % Completion | |
| Day 0 | 77.7 | 79.8 | 61.1 | 74.1 | 67.3 | 61.1 |
| Day 1 | 87.9 | 92.5 | 94.4 | 90.9 | 89.8 | 91.2 |
| Day 2 | 79.9 | 85.6 | 86.6 | 82.2 | 81.4 | 81.6 |
| Day 3 | 76.8 | 82.2 | 84.8 | 76.6 | 78.2 | 80.0 |
| Day 4 | 73.2 | 79.1 | 81.9 | 71.2 | 74.5 | 75.3 |
| Day 5 | 69.2 | 76.6 | 79.2 | 66.5 | 71.1 | 74.2 |
| Day 6 | 66.3 | 74.6 | 77.5 | 61.6 | 69.2 | 69.5 |
| Day 7 | 77.7 | 83.4 | 86.5 | 69.2 | 80.0 | 79.7 |
| Week 2 (day 14) | 77.2 | 81.8 | 85.3 | 67.1 | 78.3 | 79.1 |
| Week 3 (day 21) | 44.9 | 78.2 | 83.5 | 63.2 | 75.6 | 75.9 |
| Week 4 (day 28) | 9.8 | 75.5 | 81.9 | 60.0 | 74.4 | 74.8 |
| Week 5 (day 35) | 1.3 | 73.0 | 80.7 | 57.4 | 73.3 | 72.8 |
| Week 6 (day 42) | 0.4 | 74.0 | 81.0 | 57.7 | 73.3 | 73.2 |
*Active participants are those who completed at least one health survey in v-safe December 14, 2020 – December 13, 2021; survey completion metrics include surveys completed through November 6, 2022.